C-reactive protein and depression in persons with Human Immunodeficiency Virus infection: The Positive Living with HIV (POLH) Study

Brain, Behavior, and Immunity

Volumn 42, Issue , 2014, Pages 89-95

  Poudel Tandukar, Kalpana ^a   Bertone Johnson, Elizabeth R ^b   Palmer, Paula H ^c   Poudel, Krishna C ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c CLAREMONT GRADUATE UNIVERSITY   (United States)

Author keywords

C reactive protein; Depression; HIV; Nepal

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; EFAVIRENZ; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; TRIACYLGLYCEROL;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CD4+ T LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PHYSICAL ACTIVITY; PREVALENCE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPLICATION; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; YOUNG ADULT;

ADULT; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84908621986     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.06.004     Document Type: Article

References (72)

1. Abramson J.L., Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch. Intern. Med. 2002, 162:1286-1292.
2. American Psychiatric Association (APA), 1994. Diagnostic and Statistical Manual of Mental Disorder, fourth ed., DSM-IV: APA.
3. Amiya R.M., Poudel K.C., Poudel-Tandukar K., Kobayashi J., Pandey B.D., Jimba M. Physicians are a key to encouraging cessation of smoking among people living with HIV/AIDS: a cross-sectional study in the Kathmandu Valley, Nepal. BMC Public Health 2011, 11:677.
4. Amiya R.M., Poudel K.C., Poudel-Tandukar K., Pandey B.D., Jimba M. Perceived family support, depression, and suicidal ideation among people living with HIV/AIDS: a cross-sectional study in the Kathmandu Valley, Nepal. PLoS One 2014, 9:e90959. 10.1371/journal.pone.0090959.
5. Arseniou S., Arvaniti A., Samakouri M. HIV infection and depression. Psychiatr. Clin. Neurosci. 2014, 68:96-109. 10.1111/pcn.12097.
6. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory 1996, The Psychological Corporation, San Antonio, TX.
7. Bremmer M.A., Beekman A.T., Deeg D.J., et al. Inflammatory markers in late-life depression: results from a population-based study. J. Affect. Disord. 2008, 106:249-255.
8. Charles B., Jeyaseelan L., Pandian A.K., Sam A.E., Thenmozhi M., Jayaseelan V. Association between stigma, depression and quality of life of people living with HIV/AIDS (PLHA) in South India - a community based cross sectional study. BMC Public Health 2012, 12:463. 10.1186/1471-2458-12-463.
9. Chi D., Henry J., Kelley J., et al. The effects of HIV infection on endothelial function. Endothelium 2000, 7:223-242.
10. Ciesla J.A., Roberts J.E. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am. J. Psychiat. 2001, 158:725-730.
11. Cyranowski J.M., Marsland A.L., Bromberger J.T., Whiteside T.L., Chang Y., Matthews K.A. Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain Behav. Immun. 2007, 21:229-237.
12. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Euro. J. Pharmacol. 2004, 500:399-411.
13. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007, 21:153-160.
14. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
15. Dekker R.L., Moser D.K., Tovar E.G., et al. Depressive symptoms and inflammatory biomarkers in patients with heart failure. Euro. J. Cardiovasc. Nurs. 2013, http://cnu.sagepub.com/content/early/2013/09/20/1474515113507508. 10.1177/1474515113507508.
16. Do A.N., Rosenberg E.S., Sullivan P.S., et al. Excess burden of depression among HIV-infected persons receiving medical care in the united states: data from the medical monitoring project and the behavioral risk factor surveillance system. PLoS One 2014, 9:e92842. 10.1371/journal.pone.0092842.
17. Doyle T.A., de Groot M., Harris T., et al. Diabetes, depressive symptoms, and inflammation in older adults: results from the health, aging, and body composition study. J. Psychosom. Res. 2013, 75:419-424. 10.1016/j.jpsychores.2013.08.006.
18. Endeshaw M., Walson J., Rawlins S., et al. Stigma in ethiopia: association with depressive symptoms in people with HIV. AIDS Care 2014, 26:935-939.
19. Feldman J.G., Goldwasser P., Holman S., et al. C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. JAIDS 2003, 32:210-214.
20. Ford D.E., Erlinger T.P. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2004, 164:1010-1014.
21. Francisci D., Giannini S., Baldelli F., et al. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction. AIDS 2009, 23:589-596.
22. Geffken D.F., Cushman M., Burke G.L., Polak J.F., Sakkinen P.A., Tracy R.P. Association between physical activity and markers of inflammation in a healthy elderly population. Am. J. Epidemiol. 2001, 153:242-250.
23. Gimeno D., Kivimaki M., Brunner E.J., et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 2009, 3:413-423.
24. Gonzalez J.S., Batchelder A.W., Psaros C., Safren S.A. Depression and HIV/AIDS treatment nonadherence. A review and meta-analysis. J. Acq. Immune. Def. Synd. 2011, 58:181-187.
25. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186. 10.1097/PSY.0b013e3181907c1b.
26. Ickovics J.R., Hamburger M.E., Vlahov D., et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA 2001, 285:1466-1474.
27. Jahoor F., Gazzard B., Phillips G., et al. The acute-phase protein response to human immunodeficiency virus infection in human subjects. Am. J. Physiol. 1999, 276:E1092-E1098.
28. Khairova R.A., Machado-Vieira R., Du J., Manji H.K. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int. J. Neuropsychopharmacol. 2009, 12:561-578.
29. Kiecolt-Glaser J.K., Preacher K.J., MacCallum R.C., Atkinson C., Malarkey W.B., Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:9090-9095.
30. Kinyanda E., Hoskins S., Nakku J., Nawaz S., Patel V. Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda. BMC Psychiatry. 2011, 11:205. 10.1186/1471-244X-11-205.
31. Kohrt B.A., Kunz R.D., Koirala N.R., Sharma V.D., Nepal M.K. Validation of a Nepali version of the Beck Depression Inventory. Nepal. J. Psychiatry. 2002, 2:123-130.
32. Kohrt B.A., Speckman R.A., Kunz R.D., et al. Culture in psychiatric epidemiology: using ethnography and multiple mediator models to assess the relationship of caste with depression and anxiety in Nepal. Ann. Hum. Biol. 2009, 36:261-280.
33. Lau B., Sharrett R., Kingsley L.A., et al. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch. Intern. Med. 2006, 166:64-70.
34. Liukkonen T., Silvennoinen-Kassinen S., Jokelainen J., et al. The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol. Psychiatry. 2006, 60:825-830.
35. Maes M., Bosmans E., Suy E., Vandervorst C., De Jonckheere C., Raus J. Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 1990-1991, 24:115-120.
36. Maes M., Scharpé S., Meltzer H.Y., et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry. Res. 1993, 49:11-27.
37. Maes M., Meltzer H.Y., Bosmans E., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferring receptor in major depression. J. Affect. Disord. 1995, 34:301-309.
38. Maes M., Vandoolaeghe E., Ranjan R., Bosmans E., Bergmans R., Desnyder R. Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J. Affect. Disord. 1995, 36:29-36.
39. Maes M., Song C., Lin A., et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 1998, 10:313-318.
40. Matthews K.A., Schott L.L., Bromberger J.T., Cyranowski J.M., Everson-Rose S.A., Sowers M. Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women?. Brain Behav. Immun. 2010, 24:96-101.
41. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry. 2009, 65:732-741.
42. Morris A.A., Zhao L., Ahmed Y., et al. Association between depression and inflammation - differences by race and sex: the META-health study. Psychosom. Med. 2011, 73:462-468.
43. Muller N., Schwarz M.J., Dehning S., et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry. 2006, 11:680-684.
44. Myers G.L., Rifai N., Tracy R.P., et al. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the laboratory science discussion group. Circulation 2004, 110:e545-e549.
45. NCASC, 2007. National Estimates of HIV Infections, Nepal. Kathmandu: NCASC.
46. National Centre for AIDS and STD Control (NCASC), 2012. Nepal Country Progress Report 2012: To Contribute to Global AIDS Response Progress Report 2012. Kathmandu: NCASC.
47. Pearson T.N., Mensah G., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003, 107:499-511.
48. Pennix B.W., Kritchevsky S.B., Yaffe K., et al. Inflammatory markers and depressed mood in older persons: reasons from the health, aging, and body composition study. Biol. Psychiatry. 2003, 54:566-572.
49. Poudel K.C., Okumura J., Sherchand J.B., Jimba M., Murakami I., Wakai S. Mumbai disease in far western Nepal: HIV infection and syphilis among male migrant-returnees and non-migrants. Trop. Med. Int. Health. 2003, 8:933-939.
50. Poudel K.C., Palmer P.H., Jimba M., Mizoue T., Kobayashi J., Poudel-Tandukar K. Hepatitis C virus co-infection among HIV-positive people in the Kathmandu Valley, Nepal. J. Int. Assoc. Provid. AIDS Care 2014, 13:277-283.
51. Poudel-Tandukar K., Poudel K.C., Jimba M., Kobayashi J., Johnson C.A., Palmer P.H. Serum 25-hydroxyvitamin D levels and C-reactive protein in persons with human immunodeficiency virus infection. AIDS Res. Hum. Retrov. 2013, 29:528-534.
52. Rabkin J.G. HIV and depression: 2008 review and update. Curr. HIV/AIDS Rep. 2008, 5:163-171.
53. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
54. Ranjit N., Diez-Roux A.V., Shea S., et al. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch. Internal Med. 2007, 167:174-181.
55. Ross R. Atherosclerosis - an inflammatory disease. New Engl. J. Med. 1999, 340:115-126.
56. Salama C., Morris M., Armistead L., et al. Depressive and conduct disorder symptoms in youth living with HIV: the independent and interactive roles of coping and neuropsychological functioning. AIDS Care 2013, 25:160-168. 10.1080/09540121.2012.687815.
57. Sherr L., Clucas C., Harding R., Sibley E., Catalan J. HIV and depression - a systematic review of interventions. Psychol. Health Med. 2011, 16:493-527.
58. Shrestha S., Poudel K.C., Poudel-Tandukar K., et al. Perceived family support and depression among people living with HIV/AIDS in the Kathmandu Valley, Nepal. J. Int. Assoc. Provid. AIDS Care 2014, 13:214-222. 10.1177/1545109712456741.
59. Smith R.S. The macrophage theory of depression. Med. Hypotheses 1991, 35:298-306.
60. Spath-Schwalbe E., Hansen K., Schmidt F., Schrezenmeier, et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J. Clin. Endocrinol. Metab. 1998, 83:1573-1579.
61. Steptoe A., Hamer M., Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun. 2007, 21:901-912.
62. Stewart J.C., Rand K.L., Muldoon M.F., Kamarck T.W. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun. 2009, 23:936-944.
63. Tiemeier H., Hofman A., van Tuijl H.R., Kiliaan A.J., Meijer J., Breteler M.M. Inflammatory proteins and depression in the elderly. Epidemiology 2003, 14:103-107.
64. Tyring S., Gottlieb A., Papp K., Gordon K., et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006, 367:29-35.
65. Valkanova V., Ebmeier K.P., Allan C.L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect Disorders 2013, 150:736-744. 10.1016/j.jad.2013.06.004.
66. van den Biggelaar A.H.J., Gussekloo J., de Craen A.J.M., et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp. Gerontol. 2007, 42:693-701.
67. Vetter M.L., Wadden T.A., Vinnard C., et al. Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. Int. J. Obesity (Lond.) 2013, 37(suppl 1):S38-S43. 10.1038/ijo.2013.95.
68. Wada N., Jacobson L.P., Cohen M., et al. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am. J. Epidemiol. 2013, 177:116-125.
69. Waraich P., Goldner E.M., Somers J.M., Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can. J. Psychiatry 2004, 49:124-138.
70. Wichers M., Maes M., Wichers M., Maes M. The psychoneuroimmuno-pathophysiology of cytokine induced depression in humans. Int. J. Neuropsychopharmacol. 2002, 5:375-388.
71. Yaffe K., Kanaya A., Lindquist K., et al. The metabolic syndrome, inflammation, and risk of cognitive decline. J. Am. Med. Assoc. 2004, 292:2237-2242.
72. Zietz C., Hotz B., Sturzl M., et al. Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. Am. J. Pathol. 1996, 149:1887-1898.